This session provides dedicated coverage for important organ-specific and uncommon malignancies that may not fall within the larger disease-specific oncology categories. It supports research and clinical discussion across diverse tumor types while providing visibility for rare cancers and areas with limited patient populations.
Abstract Scope and Participation
Abstracts are welcomed on head and neck cancers, brain and central nervous system tumors, melanoma and other skin cancers, sarcoma and bone or soft-tissue tumors, thyroid and endocrine cancers, neuroendocrine tumors, and other rare malignancies. Clinical, translational, diagnostic, surgical, and therapeutic studies are encouraged.
Background : Elderly patients with papillary thyroid carcinoma (PTC) constitute a unique subgroup in clinical practice, often exhibiting more aggressive tumor characteristics. Although current…
As in some other sites of the head and neck, a broad range of tumours can arise in the nasopharynx: epithelial, mesenchymal, lymphoid, and neuro-ectodermal. However, naso-pharyngeal carcinoma (NPC)…
Objective: Pituitary adenomas (PAs) are clinically heterogeneous tumors with subtype-specific hormonal profiles, yet current therapies remain largely reactive and fail to address their proliferative…
Refractory pituitary adenomas (RPAs) and pituitary carcinomas (PCs) present significant therapeutic challenges, as they often do not respond to conventional treatment modalities such as surgery…
Squamous cell carcinoma (SCC) is the most common malignant neoplasm of the oral cavity. SCC is a major health problem for the world. Based on GLOBOCAN estimates, about 377,713 new cancer patients and…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Other Organ-Specific & Rare Cancers work, reviewed by the scientific committee.
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Other Organ-Specific & Rare Cancers research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Other Organ-Specific & Rare Cancers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Other Organ-Specific & Rare Cancers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Cancer researchers and clinicians, educators and students with an interest in Other Organ-Specific & Rare Cancers are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. CIOC 2027 is a hybrid conference — attend the Other Organ-Specific & Rare Cancers track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
